P494: An analysis of ALPL gene variants in patients with hypophosphatasia from the Global Hypophosphatasia Registry

• Priya Kishnani,
• Kathryn Dahir,
• Gabriel Martos-Moreno,
• Agnès Linglart,
• Anna Petryk,
• William Mowrey,
• Shona Fang,
• Cheryl Rockman-Greenberg,
• Keiichi Ozono,
• Wolfgang Högler,
• Lothar Seefried

Affiliations

Priya Kishnani

Duke University Medical Center, Durham, NC

Kathryn Dahir

Vanderbilt University Medical Center, Nashville, TN

Gabriel Martos-Moreno

Hospital Infantil Universitario Niño Jesús, IIS La Princesa, Universidad Autónoma de Madrid, CIBERobn, ISCIII, Madrid, Spain

Agnès Linglart

Paris-Saclay University, AP-HP and INSERM, Paris, France

Anna Petryk

Alexion, AstraZeneca Rare Disease, Boston, MA

William Mowrey

Alexion, AstraZeneca Rare Disease, Boston, MA

Shona Fang

Alexion, AstraZeneca Rare Disease, Boston, MA

Cheryl Rockman-Greenberg

University of Manitoba, Winnipeg, Manitoba, Canada

Keiichi Ozono

Osaka University, Suita, Osaka, Japan

Wolfgang Högler

Johannes Kepler University Linz, Linz, Austria

Lothar Seefried

University of Würzburg, Würzburg, Germany